| Integrated Genomic Analyses of Ovarian Carcinoma CGAR Network Nature 474 (7353), 609-615, 2011 | 6906* | 2011 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4489 | 2018 |
| Integrated Genomic and Molecular Characterization of Cervical Cancer CGAR Network Nature 543 (7645), 378-384, 2017 | 1034* | 2017 |
| Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth X Wang, S Tang, SY Le, R Lu, JS Rader, C Meyers, ZM Zheng PloS one 3 (7), e2557, 2008 | 949 | 2008 |
| Methylation associated inactivation of RASSF1A from region 3p21. 3 in lung, breast and ovarian tumours A Agathanggelou, S Honorio, DP Macartney, A Martinez, A Dallol, ... Oncogene 20 (12), 1509-1518, 2001 | 559 | 2001 |
| A comprehensive pan-cancer molecular study of gynecologic and breast cancers AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ... Cancer cell 33 (4), 690-705. e9, 2018 | 556 | 2018 |
| Cyclooxygenase-2 is overexpressed in human cervical cancer S Kulkarni, JS Rader, F Zhang, H Liapis, AT Koki, JL Masferrer, ... Clinical Cancer Research 7 (2), 429-434, 2001 | 457 | 2001 |
| A microRNA expression signature for cervical cancer prognosis X Hu, JK Schwarz, JS Lewis Jr, PC Huettner, JS Rader, JO Deasy, ... Cancer research 70 (4), 1441-1448, 2010 | 401 | 2010 |
| Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis EA Kidd, BA Siegel, F Dehdashti, JS Rader, DG Mutch, MA Powell, ... J Clin Oncol 28 (12), 2108-2113, 2010 | 329 | 2010 |
| Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6 X Wang, HK Wang, JP McCoy, NS Banerjee, JS Rader, TR Broker, ... Rna 15 (4), 637-647, 2009 | 320 | 2009 |
| Genomic, pathway network, and immunologic features distinguishing squamous carcinomas JD Campbell, C Yau, R Bowlby, Y Liu, K Brennan, H Fan, AM Taylor, ... Cell reports 23 (1), 194-212. e6, 2018 | 293 | 2018 |
| Pan-cancer Analysis of Whole Genomes ITPCAWG Consortium Nature 578 (7793), 82-93, 2020 | 276* | 2020 |
| Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers PJ Goodfellow, BM Buttin, TJ Herzog, JS Rader, RK Gibb, E Swisher, ... Proceedings of the National Academy of Sciences 100 (10), 5908-5913, 2003 | 272 | 2003 |
| Posttherapy [18F] Fluorodeoxyglucose Positron Emission Tomography in Carcinoma of the Cervix: Response and Outcome PW Grigsby, BA Siegel, F Dehdashti, J Rader, I Zoberi Journal of clinical oncology 22 (11), 2167-2171, 2004 | 260 | 2004 |
| Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy JD Wright, PW Grigsby, R Brooks, MA Powell, RK Gibb, F Gao, JS Rader, ... Cancer 110 (6), 1281-1286, 2007 | 240 | 2007 |
| Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type I Zighelboim, PJ Goodfellow, F Gao, RK Gibb, MA Powell, JS Rader, ... Journal of Clinical Oncology 25 (15), 2042-2048, 2007 | 235 | 2007 |
| Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose–positron emission tomography simulation in patients with locally advanced cervical … EA Kidd, BA Siegel, F Dehdashti, JS Rader, S Mutic, DG Mutch, ... International Journal of Radiation Oncology* Biology* Physics 77 (4), 1085-1091, 2010 | 232 | 2010 |
| Preoperative lymph node staging of early‐stage cervical carcinoma by [18F]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography JD Wright, F Dehdashti, TJ Herzog, DG Mutch, PC Huettner, JS Rader, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 221 | 2005 |
| Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer NS Horowitz, F Dehdashti, TJ Herzog, JS Rader, MA Powell, RK Gibb, ... Gynecologic oncology 95 (3), 546-551, 2004 | 213 | 2004 |
| Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer DE Cohn, F Dehdashti, RK Gibb, DG Mutch, JS Rader, BA Siegel, ... Gynecologic oncology 85 (1), 179-184, 2002 | 192 | 2002 |
